 Tuvshintugs Baljinnyam
Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thymine DNA Glycosylase | 3 | 2023 | 3 | 1.690 |
Why?
| | Smoke Inhalation Injury | 3 | 2023 | 29 | 1.490 |
Why?
| | DNA Glycosylases | 2 | 2023 | 10 | 0.950 |
Why?
| | Chlorine | 1 | 2023 | 59 | 0.790 |
Why?
| | Lyases | 1 | 2023 | 15 | 0.750 |
Why?
| | 5-Methylcytosine | 1 | 2022 | 24 | 0.730 |
Why?
| | Syndecan-1 | 1 | 2021 | 43 | 0.670 |
Why?
| | Pseudomonas Infections | 1 | 2021 | 230 | 0.580 |
Why?
| | Hyaluronic Acid | 1 | 2021 | 225 | 0.570 |
Why?
| | Burns | 2 | 2021 | 374 | 0.550 |
Why?
| | Sepsis | 2 | 2023 | 662 | 0.540 |
Why?
| | Sheep | 6 | 2023 | 876 | 0.530 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 477 | 0.520 |
Why?
| | Neutrophils | 1 | 2021 | 1123 | 0.450 |
Why?
| | DNA Repair | 4 | 2023 | 254 | 0.390 |
Why?
| | DNA | 4 | 2023 | 1433 | 0.370 |
Why?
| | Glioblastoma | 2 | 2026 | 352 | 0.360 |
Why?
| | DNA Damage | 2 | 2022 | 435 | 0.300 |
Why?
| | Disease Models, Animal | 5 | 2023 | 4552 | 0.280 |
Why?
| | Premature Birth | 2 | 2021 | 387 | 0.250 |
Why?
| | Naphthoquinones | 1 | 2026 | 20 | 0.250 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2026 | 36 | 0.240 |
Why?
| | Brain Neoplasms | 2 | 2026 | 1328 | 0.240 |
Why?
| | NAD | 1 | 2026 | 79 | 0.230 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2025 | 12 | 0.230 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2025 | 72 | 0.220 |
Why?
| | Substrate Specificity | 2 | 2023 | 383 | 0.220 |
Why?
| | Gene Deletion | 2 | 2021 | 391 | 0.210 |
Why?
| | Purines | 1 | 2025 | 186 | 0.210 |
Why?
| | Animals | 13 | 2023 | 37952 | 0.190 |
Why?
| | Mitogens | 1 | 2022 | 55 | 0.190 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2023 | 26 | 0.190 |
Why?
| | Lung | 4 | 2023 | 4101 | 0.180 |
Why?
| | Administration, Inhalation | 1 | 2023 | 571 | 0.180 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 264 | 0.170 |
Why?
| | Hippophae | 1 | 2021 | 1 | 0.170 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1261 | 0.170 |
Why?
| | Glycocalyx | 1 | 2021 | 30 | 0.170 |
Why?
| | HMGB1 Protein | 1 | 2021 | 51 | 0.170 |
Why?
| | Fish Oils | 1 | 2021 | 26 | 0.170 |
Why?
| | Capillary Permeability | 1 | 2021 | 132 | 0.160 |
Why?
| | Primary Cell Culture | 1 | 2021 | 172 | 0.160 |
Why?
| | Exosomes | 1 | 2021 | 104 | 0.160 |
Why?
| | Acute Lung Injury | 1 | 2023 | 305 | 0.150 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 250 | 0.150 |
Why?
| | Cell Movement | 2 | 2021 | 959 | 0.150 |
Why?
| | Sural Nerve | 1 | 2019 | 21 | 0.150 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2019 | 41 | 0.150 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2023 | 530 | 0.150 |
Why?
| | Facial Nerve | 1 | 2019 | 39 | 0.150 |
Why?
| | Texas | 1 | 2020 | 272 | 0.150 |
Why?
| | Nerve Regeneration | 1 | 2019 | 58 | 0.150 |
Why?
| | Telomerase | 1 | 2021 | 246 | 0.140 |
Why?
| | Wound Healing | 1 | 2021 | 354 | 0.130 |
Why?
| | Pseudomonas aeruginosa | 1 | 2021 | 395 | 0.130 |
Why?
| | Bone Marrow | 1 | 2019 | 306 | 0.130 |
Why?
| | Water | 1 | 2021 | 445 | 0.130 |
Why?
| | Survival Analysis | 1 | 2021 | 1371 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 672 | 0.130 |
Why?
| | Analysis of Variance | 1 | 2020 | 1300 | 0.130 |
Why?
| | Escherichia coli | 1 | 2021 | 834 | 0.130 |
Why?
| | Lung Injury | 1 | 2020 | 241 | 0.130 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 688 | 0.120 |
Why?
| | Mice | 7 | 2022 | 18303 | 0.120 |
Why?
| | Mice, Knockout | 2 | 2021 | 3114 | 0.110 |
Why?
| | Endothelial Cells | 1 | 2021 | 873 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2021 | 955 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2019 | 866 | 0.100 |
Why?
| | Female | 9 | 2023 | 78636 | 0.090 |
Why?
| | Cytokines | 1 | 2019 | 2048 | 0.090 |
Why?
| | Oligonucleotides | 2 | 2022 | 153 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2026 | 3539 | 0.070 |
Why?
| | Infertility, Male | 1 | 2008 | 80 | 0.070 |
Why?
| | Humans | 8 | 2026 | 145140 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 288 | 0.060 |
Why?
| | Acrylamides | 1 | 2026 | 74 | 0.060 |
Why?
| | Ribonucleotides | 1 | 2025 | 26 | 0.060 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 425 | 0.060 |
Why?
| | Piperidines | 1 | 2026 | 220 | 0.050 |
Why?
| | Neoplasms | 1 | 2019 | 2900 | 0.050 |
Why?
| | Pulmonary Gas Exchange | 1 | 2023 | 116 | 0.050 |
Why?
| | Amnion | 1 | 2022 | 31 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2021 | 2504 | 0.050 |
Why?
| | Multiple Organ Failure | 1 | 2023 | 120 | 0.050 |
Why?
| | Thymine | 1 | 2022 | 16 | 0.040 |
Why?
| | Uracil | 1 | 2022 | 36 | 0.040 |
Why?
| | Smoke | 1 | 2023 | 148 | 0.040 |
Why?
| | Cytosine | 1 | 2022 | 49 | 0.040 |
Why?
| | Gonadal Steroid Hormones | 1 | 2023 | 143 | 0.040 |
Why?
| | Signal Transduction | 2 | 2021 | 5208 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2021 | 79 | 0.040 |
Why?
| | Re-Epithelialization | 1 | 2021 | 6 | 0.040 |
Why?
| | Escherichia coli Infections | 1 | 2021 | 125 | 0.040 |
Why?
| | 3T3 Cells | 1 | 2021 | 156 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 284 | 0.040 |
Why?
| | Male | 3 | 2023 | 72664 | 0.040 |
Why?
| | Tyrosine | 1 | 2021 | 217 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2019 | 27 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2026 | 1351 | 0.040 |
Why?
| | Keratinocytes | 1 | 2021 | 249 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 571 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 7182 | 0.030 |
Why?
| | Spleen | 1 | 2019 | 507 | 0.030 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2021 | 438 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 573 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2022 | 1127 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2821 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 4310 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5972 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3410 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2876 | 0.020 |
Why?
| | Sperm Count | 1 | 2008 | 22 | 0.020 |
Why?
| | Homozygote | 1 | 2008 | 199 | 0.020 |
Why?
| | Testis | 1 | 2008 | 162 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2008 | 234 | 0.020 |
Why?
| | Spermatozoa | 1 | 2008 | 106 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2023 | 17247 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1713 | 0.010 |
Why?
| | Fibroblasts | 1 | 2008 | 1022 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2008 | 4142 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2008 | 2803 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 4071 | 0.010 |
Why?
|
|
Baljinnyam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|